Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
Nina Schor MD, PhD
Nina F. Schor MD, PhD Advisory Board
Argye Hillis MD, MA
Argye Elizabeth Hillis MD, MA Associate Editor
See All Experts
Published in Neurology

Journal Scan / Research · January 24, 2022

Rivaroxaban vs Aspirin in Patients With LV Dysfunction and Embolic Stroke of Undetermined Source

JAMA Neurology

 

 Save  Recommend
 Share

Additional Info

JAMA Neurology
Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial
JAMA Neurol 2021 Dec 01;78(12)1454-1460, AE Merkler, LA Pearce, SE Kasner, A Shoamanesh, LA Birnbaum, H Kamel, KN Sheth, R Sharma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated